
DR. PHILIP E. CRYER PASSED AWAY ON FEBRUARY 24, 2024. READ THE FORMAL OBITUARY.
In 1965, Philip E. Cryer arrived at Barnes Hospital as a house officer in medicine. After house staff training, a fellowship in endocrinology and metabolism, and two years at the Naval Medical Research Institute of Bethesda, Maryland, Dr. Cryer became Chief Resident in Medicine at Barnes. Soon after, joining Washington University in 1971 as a an Instructor. In 1981, he rose to the rank of Professor of Medicine and served as the Irene E. and Michael M. Karl Professor of Endocrinology and Metabolism from 1985 until he became Emeritus in 2014. From 1973 to 2006, Dr. Cryer headed the Washington University General Clinical Research Center, leading it through six NIH site visits. He served as Director of the Division of Endocrinology, Diabetes and Metabolism from 1985 to 2002.
Read more about Dr. Philip E. Cryer’s story, here.
Past Lectures

Thursday, October 17, 2024
“Advancements in Insulin Delivery Technology: New Treatment Options for Glycemic Control”
Sue A. Brown, MD
Gerald D. Aurbach Professor of Endocrinology
University of Virginia Center for Diabetes Technology

Thursday, October 13, 2022
“Hypoglycemia Associated Autonomic Failure and Reversal in Type 1 Diabetes”
Michael R. Rickels, MD, MS
Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases
Director, Clinical Science
Division of Endocrinology, Diabetes & Metabolism
University of Pennsylvania Perelman School of Medicine

Thursday, September 5, 2019
“From AID to GLP (and SGLT) to TIR: Predicting the Next Era of Diabetes Treatment”
Irl B. Hirsch, MD
Professor of Medicine
Diabetes Treatment and Teaching Chair
University of Washington Medicine Diabetes Institute

Thursday, October 5, 2017
“The Role of the Liver in Postprandial Glucose Disposition”
Alan D. Cherrington, PhD
Professor, Molecular Physiology & Biophysics
Jacquelyn A. Turner & Dr. Dorothy J. Turner
Chair in Diabetes Research
Vanderbilt University School of Medicine

Thursday, September 15, 2016
“Functional Genetics of IGF2 mRNA Binding Protein, A Candidate Type 2 Diabetes Gene”
Joseph Avruch, MD
Hansgeorg Gareis Distinguished Investigator
Department of Molecular Biology
Massachusetts General Hospital
Professor of Medicine
Harvard Medical School

Thursday, September 3, 2015
“The Challenge of Beta Cell Replacement Therapy: From its Beginning in St. Louis”
Gordon C. Weir, MD
Professor of Medicine, Harvard Medical School
Diabetes Research and Wellness Chair
Joslin Diabetes Center
Co-Head, Section on Islet Cell and
Regenerative Biology